Kalkine has a fully transformed New Avatar.

small-cap

One Branded Frozen Foods Provider with Healthy Dividend Yield in a Buy Zone – BGS

Apr 07, 2021 | Team Kalkine
One Branded Frozen Foods Provider with Healthy Dividend Yield in a Buy Zone – BGS

 

 

B&G Foods, Inc.

BGS Details

Based in Parsippany, New Jersey, B&G Foods, Inc. (NYSE: BGS), along with its subsidiaries, is engaged in manufacturing, selling and distributing high-quality, branded shelf-stable and frozen foods across the United States, Canada and Puerto Rico.

FY20 Results Performance

The company has delivered a healthy performance in FY20 and net sales increased by 18.5% YoY with net sales from base business grew by 14.7% YoY. This growth was mainly attributed to sharp rise in demand for its products on the back of COVID-19 pandemic. Further, the growth in sales was supported by the acquisitions and also due to the inclusion of additional one reporting week in FY20. In line with decent growth in sales, the company witnessed 19.4% YoY rise in its adjusted EBITDA to $361.2 million.

Financial Snapshot (Source: Company Reports)

Dividend Update

The company on 1 March 2021 declared a regular quarterly cash dividend of $0.475 per share. The dividend would be paid on 30th April 2021.

Outlook

The company anticipates that its net sales in FY21 are likely to be around $2.05 billion to $2.10 billion which will benefit from the extra eleven months of ownership of the Crisco brand.

Valuation Methodology: EV/Sales Based Relative Valuation (Illustrative)

Stock Recommendation

The company’s rich portfolio mix with a good quality of brands and products, continued strong momentum in consumer demand for its products, and continued acceleration in sales momentum would aid the company in tapping future growth opportunities. We have applied EV/Sales multiple based relative valuation (on an illustrative basis) and the target price reflects a rise of low double-digit (in % terms). We have applied some discount to peer average EV/Sales multiple because of risks related to higher debt profile and rise in SG&A expenses.

The first resistance has been made at US$41.669 and first support at US$27.18.

Thus, we give a “Buy” recommendation on the stock at the current market price of US$30.34 per share, up by 0.2% on April 5, 2021.

 

BGS Daily Technical Chart (Source: Refinitiv (Thomson Reuters))


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine do not hold interests in any of the securities or other financial products covered on the Kalkine website.